Literature DB >> 13560962

[Existence of type D botulism in man].

J DEMARCHI, C MOURGUES, J ORIO, A R PREVOT.   

Abstract

Entities:  

Keywords:  BOTULISM

Mesh：

Year:  1958        PMID： 13560962

Source DB:  PubMed          Journal:  Bull Acad Natl Med        ISSN： 0001-4079            Impact factor:   0.144


× No keyword cloud information.
  13 in total

1.  Studies on immunity to toxins of Clostridium botulinum. VI. Purification and detoxification of type D toxin and the immunological response to toxoid.

Authors:  M A CARDELLA; J T DUFF; B H WINGFIELD; C GOTTFRIED
Journal:  J Bacteriol       Date:  1960-03       Impact factor: 3.490

2.  Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.

Authors:  T J Smith; J Lou; I N Geren; C M Forsyth; R Tsai; S L Laporte; W H Tepp; M Bradshaw; E A Johnson; L A Smith; J D Marks
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Activity of botulinum neurotoxin type D (strain 1873) in human neurons.

Authors:  Sabine Pellett; William H Tepp; Jacob M Scherf; Christina L Pier; Eric A Johnson
Journal:  Toxicon       Date:  2015-04-30       Impact factor: 3.033

4.  Staphylococcal food poisoning and botulism.

Authors:  R J Gilbert
Journal:  Postgrad Med J       Date:  1974-10       Impact factor: 2.401

5.  Botulinum toxin type D blocks autonomic cholinergic synapses in humans: discussion of a potential therapeutic use.

Authors:  Dirk Dressler; Katja Kollewe; Tilmann H C Kruger; Niklas Gade; Stefan Sikorra; Hans Bigalke
Journal:  J Neural Transm (Vienna)       Date:  2019-06-15       Impact factor: 3.575

6.  Clinical Guidelines for Diagnosis and Treatment of Botulism, 2021.

Authors:  Agam K Rao; Jeremy Sobel; Kevin Chatham-Stephens; Carolina Luquez
Journal:  MMWR Recomm Rep       Date:  2021-05-07

7.  Universal and specific quantitative detection of botulinum neurotoxin genes.

Authors:  Brenna J Hill; Janet C Skerry; Theresa J Smith; Stephen S Arnon; Daniel C Douek
Journal:  BMC Microbiol       Date:  2010-10-20       Impact factor: 3.605

8.  Therapeutic efficacy of equine botulism antitoxin in Rhesus macaques.

Authors:  Shantha Kodihalli; Andrew Emanuel; Teresa Takla; Yi Hua; Charles Hobbs; Ross LeClaire; Denise C O'Donnell
Journal:  PLoS One       Date:  2017-11-22       Impact factor: 3.240

9.  Pharmacokinetics of Human Recombinant Anti-Botulinum Toxin Antibodies in Rats.

Authors:  Yero Espinoza; David Wong; Ago Ahene; Kenneth Der; Zachary Martinez; John Pham; Ronald R Cobb; Shauna Farr-Jones; James D Marks; Milan T Tomic
Journal:  Toxins (Basel)       Date:  2019-06-17       Impact factor: 4.546

10.  Therapeutic efficacy of equine botulism heptavalent antitoxin against all seven botulinum neurotoxins in symptomatic guinea pigs.

Authors:  Douglas Barker; Karen T Gillum; Nancy A Niemuth; Shantha Kodihalli
Journal:  PLoS One       Date:  2019-09-17       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.